---
title: "Mavacamten inhibits diaphragm myosin in vitro, with greater potency on slow fibers"
id: "biorxiv-0-beta-myosin-inhibition-in-skeletal-muscle-impact-of-mavacamten-on-the-diaphragm"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-0-beta-myosin-inhibition-in-skeletal-muscle-impact-of-mavacamten-on-the-diaphragm"
content_type: "clinical_feed_article"
specialty: "Pulmonology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.17.767324v1?rss=1"
published_at: "2026-11-21T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Mavacamten inhibits diaphragm myosin in vitro, with greater potency on slow fibers
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-0-beta-myosin-inhibition-in-skeletal-muscle-impact-of-mavacamten-on-the-diaphragm
- **Specialty:** [Pulmonology](https://medichelpline.com/clinical-feed/pulmonology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.17.767324v1?rss=1)
- **Published At:** 2026-11-21T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Investigators used an in vitro motility assay to test **Mavacamten** effects on native myosins isolated from rabbit diaphragm muscle. - Data indicated a dose-dependent reduction in myosin-driven actin filament velocity; the reported apparent IC50 was 1350 nM. - The inhibitory effect reversed after drug washout, and therefore the study team described it as non-permanent modulation rather than irreversible damage. - Pure isoforms from slow-twitch M. soleus and fast-twitch M. psoas were tested to determine fiber-type specificity; both isoforms were inhibited by the drug. - The cohort showed that slow skeletal myosin was ~20-fold more sensitive to inhibition than fast skeletal myosin; authors noted slow myosin sensitivity exceeded that of beta-cardiac myosin. - Mechanistic experiments separated two apparent modes of action: promotion of an OFF state that likely reduces the active motor pool, and direct modulation of the actomyosin biochemical cycle. - Given the diaphragm contains nearly equal proportions of slow (Type I) and fast (Type II) fibers, authors argued these off-target effects could impair respiratory performance in treated patients. - The study is an in vitro preprint; the authors recommended respiratory function monitoring for patients on **Mavacamten**. - The source did not report in vivo dosing, clinical respiratory measurements, or patient-level safety data in this report.
## Clinical Analysis & Structured Key Points
[Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.17.767324v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.17.767324v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Beta-Myosin inhibition in skeletal muscle: Impact of Mavacamten on the diaphragm Ayesha Sarfraz, Arnab Nayak, Tim Holler, Theresia Kraft, [ View ORCID Profile](http://orcid.org/0000-0001-8582-3986)Mamta Amrute-Nayak doi: https://doi.org/10.64898/2026.11.17.767324 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Ayesha Sarfraz Hannover Medical School * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ayesha%2BSarfraz%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Sarfraz%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AAyesha%2BSarfraz%2B) Arnab Nayak Hannover Medical School * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Arnab%2BNayak%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Nayak%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AArnab%2BNayak%2B) Tim Holler Hannover Medical School * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Tim%2BHoller%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Holler%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ATim%2BHoller%2B) Theresia Kraft Hannover Medical School * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Theresia%2BKraft%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Kraft%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ATheresia%2BKraft%2B) Mamta Amrute-Nayak Hannover Medical School * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mamta%2BAmrute-Nayak%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Amrute-Nayak%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMamta%2BAmrute-Nayak%2B) * [ORCID record for Mamta Amrute-Nayak](http://orcid.org/0000-0001-8582-3986 "Open in new tab") * For correspondence: amrute.mamta@mh-hannover.de * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.17.767324v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5986159/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.17.767324v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5986159/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.17.767324v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5986159/1) * [Supplementary material](https://www.biorxiv.org/content/10.64898/2026.11.17.767324v1.supplementary-material)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_data/node:5986159/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.17.767324v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5986159/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract The diaphragm, a primary respiratory muscle, contains nearly equal proportions of slow, Type-1 and fast, Type-II muscle fibers. Muscle fiber types - classified based on their shortening velocities and force generation abilities - are largely determined by distinct myosin II isoforms. Mavacamten (MAVA), a small molecule inhibitor of beta-cardiac myosin ATPase, is currently used for the treatment of obstructive Hypertrophic Cardiomyopathy (HOCM). Notably, beta-myosin heavy chain (beta-MyHC) is not restricted to the ventricular myocardium but is also expressed in slow fibers, raising concerns about off-target effects of therapy used to treat cardiomyopathic conditions. Given that nearly 50 % of the fibers express beta-MyHC in the diaphragm, we hypothesize that Mava may affect diaphragm muscle activity. Using an in vitro motility assay, we investigated the effects of Mava on native myosins isolated from rabbit diaphragm muscle and measured the velocity of actin and regulated thin filaments. Mava caused a dose-dependent decrease in myosin-driven actin filament velocity, with an apparent IC50 of 1350 nM. Importantly, this inhibition was reversible upon drug washout, indicating a non-permanent modulatory effect. To determine the drugs fiber-type specificity, we tested pure slow- and fast-myosin isoforms from the slow-twitch M. soleus and fast-twitch M. psoas. Both isoforms were inhibited by Mava, but slow myosin exhibited nearly 20-fold greater sensitivity than fast myosin, suggesting a potentially stronger impact on slow fibers. Interestingly, the slow myosin isoform showed even higher sensitivity to Mava than beta-cardiac myosin. Further mechanistic analysis distinguished two modes of action: (i) promotion of the OFF state of myosin, likely reducing a pool of active motors interacting with actin filaments, and (ii) modulation of the actomyosin biochemical cycle. Altogether, given the diaphragms reliance on both fiber types for sustained respiratory function, this off-target effect may impair respiratory performance in patients undergoing therapy, underscoring the need for respiratory function monitoring. The studies have direct implications for understanding the modulation of myosin function under physiological and pathophysiological conditions, as well as following pharmacological interventions. ### Competing Interest Statement The authors have declared no competing interest. ## Funder Information Declared Deutsche Forschungsgemeinschaft, https://ror.org/018mejw64, Project number: 530881940 Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.11.17.767324v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.11.19.767541v1 "Training background shapes the exercise-induced extracellular vesicle proteome to acute exercise with partial overlap with cold exposure in humans")[Next ](https://www.biorxiv.org/content/10.64898/2026.11.18.767671v1 "Interspecies differences in lamina cribrosa fiber composition and architecture might arise from differences in optic nerve head size and mechanical constraints") Posted November 21, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.11.17.767324v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/11/21/2026.11.17.767324.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [Supplementary Material ](https://www.biorxiv.org/content/10.64898/2026.11.17.767324v1.supplementary-material) [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) Beta-Myosin inhibition in skeletal muscle: Impact of Mavacamten on the diaphragm Ayesha Sarfraz, Arnab Nayak, Tim Holler, Theresia Kraft, Mamta Amrute-Nayak bioRxiv 2026.11.17.767324; doi: https://doi.org/10.64898/2026.11.17.767324 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.17.767324v1%26text%3DBeta-Myosin%2520inhibition%2520in%2520skeletal%2520muscle%253A%2520Impact%2520of%2520Mavacamten%2520on%2520the%2520diaphragm "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.17.767324v1%26t%3DBeta-Myosin%2520inhibition%2520in%2520skeletal%2520muscle%253A%2520Impact%2520of%2520Mavacamten%2520on%2520the%2520diaphragm "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.17.767324v1%26title%3DBeta-Myosin%2520inhibition%2520in%2520skeletal%2520muscle%253A%2520Impact%2520of%2520Mavacamten%2520on%2520the%2520diaphragm%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.17.767324v1%26title%3DBeta-Myosin%2520inhibition%2520in%2520skeletal%2520muscle%253A%2520Impact%2520of%2520Mavacamten%2520on%2520the%2520diaphragm "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") [ Get QR code](https://connect.biorxiv.org/qr/2026.11.17.767324) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.64898/2026.11.17.767324v1&count=horizontal&via=&text=Beta-Myosin%20inhibition%20in%20skeletal%20muscle%3A%20Impact%20of%20Mavacamten%20on%20the%20diaphragm&counturl=www.biorxiv.org/content/10.64898/2026.11.17.767324v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.biorxiv.org/content/early/recent) * [Animal Behavior and Cognition](https://www.biorxiv.org/collection/animal-behavior-and-cognition) (8164) * [Biochemistry](https://www.biorxiv.org/collection/biochemistry) (19027) * [Bioengineering](https://www.biorxiv.org/collection/bioengineering) (15171) * [Bioinformatics](https://www.biorxiv.org/collection/bioinformatics) (46185) * [Biophysics](https://www.biorxiv.org/collection/biophysics) (22958)
## Related Clinical Research

- [Xist deletion in T cells reduces influenza-driven lung injury in female mice](https://medichelpline.com/clinical-feed/biorxiv-4-xist-deletion-in-t-cells-protects-against-influenza-induced-lung-injury.md)
- [EPIC2: integrate single-cell chromatin accessibility with GWAS to pinpoint trait-relevant cell typ](https://medichelpline.com/clinical-feed/biorxiv-3-epic2-integrating-single-cell-chromatin-accessibility-with-human-genetics-to.md)
- [Motherly Plus trial: Smartphone‑assisted single‑session psychotherapy for postpartum depression](https://medichelpline.com/clinical-feed/medrxiv-3-motherly-plus-study-protocol-of-a-randomized-controlled-trial-evaluating-a.md)
- [Cell-type X-chromosome Regulation Identifies Sex-Biased Genes Linked to Neurodegeneration](https://medichelpline.com/clinical-feed/medrxiv-16-brain-cell-type-specific-x-chromosome-gene-regulation-reveals-sex-biased.md)
- [Context-dependent roles of DJ-1 (PARK7) in oxidative-stress diseases: neuroprotection versus tumor](https://medichelpline.com/clinical-feed/pubmed-43059404.md) (DOI: 10.3892/mmr.2026.14076)

## Navigation
- [← Back to Pulmonology Feed](https://medichelpline.com/clinical-feed/pulmonology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.